Page last updated: 2024-09-02

thromboxanes and Chronic Kidney Diseases

thromboxanes has been researched along with Chronic Kidney Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dannenberg, L; Hohlfeld, T; Kelm, M; Levkau, B; Polzin, A; Sansone, R; Zeus, T	1

Other Studies

1 other study(ies) available for thromboxanes and Chronic Kidney Diseases

Article	Year
Antiplatelet effects of aspirin in chronic kidney disease patients. Journal of thrombosis and haemostasis : JTH, 2016, Volume: 14, Issue:2 Topics: Aged; Aged, 80 and over; Arachidonic Acid; Aspirin; Blood Platelets; Cardiovascular Diseases; Cross-Sectional Studies; Drug Resistance; Female; Glomerular Filtration Rate; Humans; Kidney; Linear Models; Male; Middle Aged; Odds Ratio; Platelet Aggregation Inhibitors; Platelet Function Tests; Predictive Value of Tests; Renal Insufficiency, Chronic; Risk Factors; Severity of Illness Index; Thromboxanes	2016

Article

Year

Antiplatelet effects of aspirin in chronic kidney disease patients.

Journal of thrombosis and haemostasis : JTH, 2016, Volume: 14, Issue:2

Topics: Aged; Aged, 80 and over; Arachidonic Acid; Aspirin; Blood Platelets; Cardiovascular Diseases; Cross-Sectional Studies; Drug Resistance; Female; Glomerular Filtration Rate; Humans; Kidney; Linear Models; Male; Middle Aged; Odds Ratio; Platelet Aggregation Inhibitors; Platelet Function Tests; Predictive Value of Tests; Renal Insufficiency, Chronic; Risk Factors; Severity of Illness Index; Thromboxanes

2016